HomeNewsBusinessCipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

Cipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

Net Sales are expected to increase by 5.6 percent Q-o-Q (up 17.9 percent Y-o-Y) to Rs 3852.5 crore, according to ICICI Securities. Cipla to report net profit at 326.3 crore up 7.3% quarter-on-quarter.

April 17, 2017 / 13:17 IST
Story continues below Advertisement
An employee works at the reception area of Cipla at its headquarters in Mumbai, India June 17, 2015. Cipla Ltd, India's fourth-largest drugmaker by sales, is planning to enter Latin America and Eastern Europe to tap into growing demand for generic drugs in emerging markets, Chief Executive Subhanu Saxena said.REUTERS/Danish Siddiqui - RTX1GUYK
An employee works at the reception area of Cipla at its headquarters in Mumbai, India June 17, 2015. Cipla Ltd, India's fourth-largest drugmaker by sales, is planning to enter Latin America and Eastern Europe to tap into growing demand for generic drugs in emerging markets, Chief Executive Subhanu Saxena said.REUTERS/Danish Siddiqui - RTX1GUYK

ICICI Securities has come out with its fourth quarter (January-March) earnings estimates for the Healthcare sector. The brokerage house expects Cipla to report net profit at 326.3 crore up 7.3% quarter-on-quarter.

Net Sales are expected to increase by 5.6 percent Q-o-Q (up 17.9 percent Y-o-Y) to Rs 3852.5 crore, according to ICICI Securities.

Story continues below Advertisement

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 4.2 percent Q-o-Q (up 60.1 percent Y-o-Y) to Rs 706.2 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.